The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain.

IF 1.9 4区 医学 Q3 OBSTETRICS & GYNECOLOGY
Emilio Arisi, Cosima Bauer, Manuela Farris, Chiara Giulini-Limbach, Anna Glasier, Inaki Lete, Uwe May, Noushin Mirjalili, Rossella E Nappi, Rafael Sanchez-Borrego, Isabel Serrano
{"title":"The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain.","authors":"Emilio Arisi,&nbsp;Cosima Bauer,&nbsp;Manuela Farris,&nbsp;Chiara Giulini-Limbach,&nbsp;Anna Glasier,&nbsp;Inaki Lete,&nbsp;Uwe May,&nbsp;Noushin Mirjalili,&nbsp;Rossella E Nappi,&nbsp;Rafael Sanchez-Borrego,&nbsp;Isabel Serrano","doi":"10.1080/13625187.2022.2128643","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To explore the perceived need and enthusiasm for over the counter (OTC) progestogen-only pills (POP).</p><p><strong>Materials and methods: </strong>A web-based survey of 1000 sexually active women (16-45) and 100 pharmacists in Germany, Italy and Spain.</p><p><strong>Results: </strong>Despite not wanting to conceive, 5-6% of women in each country were not using contraception and 8-20% were using methods less effective than condoms. At least 74% of respondents felt knowledgeable about the different contraceptives available but at least 1/3 had experienced difficulty accessing oral contraceptive (OCs) in the past two years. The cost of contraceptives, the need to see a doctor and long waits for appointments were cited as barriers for not using OCs. The majority agreed they would discuss with their doctor the decision to buy the POP, consult about side effects and other reproductive health issues. Over 2/3 of pharmacists in each country would be very, or fairly, likely to recommend the POP, agreeing that the benefits included improved access for women, and offered them more independence.</p><p><strong>Conclusions: </strong>Asked directly, women in Germany, Spain and Italy currently using contraception are positive about a POP OTC. Pharmacists are also positive, with the overwhelming majority in favour of providing POPs.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Contraception and Reproductive Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13625187.2022.2128643","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose: To explore the perceived need and enthusiasm for over the counter (OTC) progestogen-only pills (POP).

Materials and methods: A web-based survey of 1000 sexually active women (16-45) and 100 pharmacists in Germany, Italy and Spain.

Results: Despite not wanting to conceive, 5-6% of women in each country were not using contraception and 8-20% were using methods less effective than condoms. At least 74% of respondents felt knowledgeable about the different contraceptives available but at least 1/3 had experienced difficulty accessing oral contraceptive (OCs) in the past two years. The cost of contraceptives, the need to see a doctor and long waits for appointments were cited as barriers for not using OCs. The majority agreed they would discuss with their doctor the decision to buy the POP, consult about side effects and other reproductive health issues. Over 2/3 of pharmacists in each country would be very, or fairly, likely to recommend the POP, agreeing that the benefits included improved access for women, and offered them more independence.

Conclusions: Asked directly, women in Germany, Spain and Italy currently using contraception are positive about a POP OTC. Pharmacists are also positive, with the overwhelming majority in favour of providing POPs.

妇女和药剂师对仅使用孕激素的非处方避孕药的看法。这是一项在德国、意大利和西班牙进行的调查结果。
目的:探讨非处方(OTC)孕激素单药(POP)的感知需求和热情。材料和方法:对德国、意大利和西班牙的1000名性活跃女性(16-45岁)和100名药剂师进行网络调查。结果:尽管不想怀孕,但每个国家5-6%的妇女没有使用避孕措施,8-20%的妇女使用的方法比避孕套效果差。至少74%的回答者对可获得的各种避孕药具有所了解,但至少三分之一的回答者在过去两年中难以获得口服避孕药。避孕药具的费用、看医生的需要和预约的长时间等待被认为是不使用OCs的障碍。大多数人同意,他们会与医生讨论购买POP的决定,咨询副作用和其他生殖健康问题。每个国家都有超过2/3的药剂师非常或相当有可能推荐POP,他们认为该计划的好处包括改善了女性获得药物的机会,并为她们提供了更多的独立性。结论:直接询问德国、西班牙和意大利目前使用避孕药的妇女,她们对POP非处方药持肯定态度。药剂师也持积极态度,绝大多数人赞成提供持久性有机污染物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
11.80%
发文量
63
审稿时长
>12 weeks
期刊介绍: The Official Journal of the European Society of Contraception and Reproductive Health, The European Journal of Contraception and Reproductive Health Care publishes original peer-reviewed research papers as well as review papers and other appropriate educational material.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信